“We do not know the full impact,” Fauci said during a discussion with Randi Weingarten, president of the American Federation of Teachers. “We do not have a complete database of information on what to expect.”
As states tried to allow businesses to reopen their doors, the nation continued to discuss how and when it would be safe to send students back to school.
Some states have begun implementing plans to increase the safety of personal learning and online education. Tennessee has announced testing and arrangements to monitor contacts within schools. Oregon has set limits on schools that students can afford, and Connecticut is investing $ 43.5 million in providing digital devices to enable students to learn remotely.
Although Fauci said there was no “one-way answer”; to how schools should reopen, he reiterated that “the starting point should be that we should try our best to get our children back to school.”
“With cautious optimism, I feel it reasonable to say that we will have a safe and effective vaccine by December.”
The vaccine prevents serious diseases and prevents it from spreading
The experimental vaccine Moderny is moving fast and is showing promising results when phase 3 testing begins.
The vaccine, which was developed by the National Institute of Allergies and Infectious Diseases, began testing in humans on Monday, making it the fastest progress in developing a new vaccine in the United States.
The vaccine was tested on rhesus monkeys. And while it is unclear whether the vaccine will affect humans as it does in primates, test results show that after two days, most infected monkeys no longer had detectable levels of the virus in their lungs, NIAID scientists said in a statement.
None of the monkeys that received the higher dose of the vaccine had the virus in their noses. This would suggest that the vaccine could prevent the virus from spreading, even if people become infected.
“This is the first time that the experimental vaccine COVID-19 tested in non-human primates has been shown to cause such rapid viral control in the upper respiratory tract,” the researchers said.
If the vaccine did the same for humans, it could significantly reduce the spread of disease.
Hydroxychloroquine rumors divert attention from the “strongest weapon” available
However, the drug has not been shown to be effective against coronavirus and may even cause harmful side effects, a former US surgeon, Dr. Blitzer CNN, said on Tuesday. Vivek Murthy.
“All the while we often end up passing these myths about hydroxychloroquine is a time we don’t spend working on the real problem ahead,” Murthy said.
Measures to combat the spread of the virus could already be the key to solving the problem, the director of the American Center for Disease Control and Prevention, Dr., told the ABC newspaper on Tuesday. Robert Redfield.
“We currently have the most powerful weapon in our hands, I think it’s an extremely powerful weapon. It’s just a simple, weak mask, “said Redfield. “This virus can be defeated if people simply wear a mask.”
Numbers on the drop after face mask requirements
Although some states continue to rise sharply and have seen coronavirus and hospitalization cases, the total number of new cases on Tuesday across the country reached 56,336, the second lowest in 20 days. The country’s seven-day average for new cases was 65,083 Monday, the lowest level since July 15.
Kentucky, a state that is among at least 41 requiring masks, reported 532 new cases on Tuesday and a positivity rate of 5.08%, which fell for the first time in four days, Andy Beshear said.
“Again, too soon to draw conclusions, but I hope I said I hope we’re starting to see it, because it’s the right time when the demand for facial coverage is starting to deepen and help,” Beshear added. .
Fauci reiterated a series of states that still see a sharp rise: wipe masks, social distances, narrow bars where spread is high, wash your hands, and reopen economies in stages.
“We hope that all states will now reconsider what will happen if you do not stick,” Fauci said.
Andrea Kane, Shelby Lin Erdman, Annie Grayer, Maggie Fox, Rebekah Riess, Steve Almasy and Christina Maxouris contributed to this report.